HB 3868
House·20th Congress·Filed Aug 20, 2025
An Act Increasing Access to Cancer and Related Care Medicines by Mandating an Automatic or Expedited Licensing and Registration Process of Antineoplastic Drugs Sourced Overseas, While Ensuring Their Availability at Affordable Prices, Appropriating Funds Therefor, Amending for the Purpose Republic Act No. 11215, Otherwise Known as "National Integrated Cancer Control Act"
In plain language
The bill would let the FDA fast‑track approval of cancer drugs, both made in the Philippines and imported, as long as they meet basic quality standards, and would require the Department of Health to make those drugs available throughout the country at prices that are affordable to patients.
HealthPublic Works and Infrastructure
Automated summary by BatasWatch. It may miss nuance — read the bill text before citing it.
Author · Representative
Official sources
Spot something wrong?
Printed from CivicSync PH: https://civicsync-ph-gamma.vercel.app/bills/HB03868. Status changes over time; check the link for the latest.
HB03868 · Sources: BetterGov Open Congress, BatasWatch